r/ProstateCancer • u/Independent-Golf120 • 3h ago
Question Turp should be done or urine flow should be observed for 2-3 months without catheter?
My father is diagnosed with a prostate cancer with Gleason 5+4=9 in the age of 65. The urine flow was very little after the prosate cancer was known through biospy. But the urine flow completely stopped after psma pet scan, only a little drop during excretion was absorbed. Then after 1-2 days of psma test, his sodium level decreased to 105 and he was admitted for 7 days for sodium and potassium recovery along with usage of catheter tube for urination. After 1 months, the urologist suggested bilateral sub capsular orchidectomy and TURP to minimise cancer spread and ease urine respectively.
But during the operation day, the infection was seen in urine which was not cured in 5 days and only orchidectomy was done. The doctor has suggested to remove catheter and check urine flow after 15 days and if urine don’t ease, turp should be performed quickly. So i want to know should we wait and observe urine flow for few months before TURP or TURP should be done immediately.
The disease summary are-
DISEASES MANAGEMENT SUMMARY:
Bilateral Subcapsular Orchidectomy on 4th November 2026 for Carcinoma Prostate
BRIEF CASE SUMMARY:
HISTORY OF PRESENT ILLNESS:
The patient was diagnosed with high-grade prostatic adenocarcinoma following evaluation and investigations. 19/08/2026: TRUS-guided prostatic biopsy histopathology revealed conventional acinar adenocarcinoma involving all 12/12 cores, Grade Group 5 (Gleason Score 4+5=9), with maximum core involvement of 90% (left mid medial) and perineural invasion in the right apex lateral core. No lymphovascular invasion, intraductal carcinoma, or cribriform glands were identified. 24/08/2026 AD (2083/05/08 BS): CEMRI of the prostate revealed prostatomegaly (3.5 x 4.1 x 4.2 cm; volume 30.1 g) with an ill- defined, diffusely infiltrative lesion involving all zones of the prostate from base to apex, showing restricted diffusion and heterogeneous enhancement. Prostatic capsule and seminal vesicles were intact, with no neurovascular bundle invasion. Two enlarged right obturator lymph nodes were noted, the largest measuring approximately 13 x 7 x 10.5 mm. Total PSA was 31.6 ng/ml, with PSA density of 1.04 ng/mL/cc. Foley catheter was noted in situ.
03/09/2026: 18F-PSMA PET-CT demonstrated prostatomegaly with heterogeneous PSMA-avid lesions throughout the prostate (SUV max 20.39), without seminal vesicle involvement. PSMA-avid metastatic lymph nodes were identified in the left mesorectal, right presacral, right obturator (largest 14 x 11 mm; SUV max 12.14), and left external iliac regions. Tiny non- PSMA-avid nodular opacities were noted in the right upper and middle lung lobes (largest 2.5 mm), too small to characterize. Bilateral simple renal cortical cysts were also noted. No PSMA-avid osseous lesions were identified.
2083/05/22 BS: USG abdomen and pelvis revealed post-cholecystectomy status, minimal bilateral pleural effusion, and an empty urinary bladder with Foley catheter in situ. No abdominopelvic free fluid or significant lymphadenopathy was noted. 28/10/2026: 99mTc-MDP bone scan with SPECT revealed no definite scintigraphic evidence of metastatic osteoblastic bone disease. Mildly increased focal uptake was noted in the right 6th lateral rib and right 7th costochondral junction, likely post- traumatic/inflammatory in nature.
29/10/2026 AD (2083/07/12 BS): The patient was evaluated for node-positive metastatic prostate cancer and planned for bilateral subcapsular orchidectomy (Bil. SCO) + channel TURP + hormone therapy. Routine preoperative investigations and pre- anesthetic checkup were advised. Baseline investigations revealed Hb 12.1 g/dL, WBC 7,290/cumm, platelets 2,16,000/cumm, PT/INR 15.7 sec/1.18, RBS 135 mg/dL, urea 11 mg/dL, creatinine 1.02 mg/dL, sodium 137 mEq/L, and potassium 4.3 mEq/L. Blood group was B Rh positive, with negative HBsAg, Anti-HCV, and Anti-HIV serologies. Routine urine examination showed 6-8 pus cells/hpf. In view of a previous urine culture showing Klebsiella sensitive to Nitrofurantoin, the patient was advised Uribid (Nitrofurantoin) 100 mg BD, and repeat urine culture was requested.
01/11/2026-03/11/2026 AD (2083/07/15-2083/07/17 BS): Repeat urine culture and sensitivity isolated Klebsiella oxytoca after 24 hours of incubation. The organism was resistant to Nitrofurantoin, Amikacin, Ceftriaxone, Cefuroxime, Doxycycline, Gentamicin, Imipenem, Levofloxacin, and Piperacillin-Tazobactam, while sensitive to Ciprofloxacin, Colistin, Cotrimoxazole, Norfloxacin, Polymyxin B, Tetracycline, and Tigecycline.
After all workup surgery was planned
